These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24048165)

  • 21. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
    Burri E; Beglinger C
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):197-210. PubMed ID: 24345070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Calprotectin Rise in Chronic Granulomatous Disease-Associated Colitis.
    Nakazawa Y; Kawai T; Arai K; Tamura E; Uchiyama T; Onodera M
    J Clin Immunol; 2017 Nov; 37(8):741-743. PubMed ID: 28879453
    [No Abstract]   [Full Text] [Related]  

  • 23. Calprotectin: a predictive marker of a relapse in ulcerative colitis.
    Isselbacher KJ
    Postgrad Med; 2005 May; 117(5):8. PubMed ID: 15948362
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?
    Caccaro R; D'Incà R; Pathak S; Sturniolo GC
    Expert Rev Clin Immunol; 2012 Aug; 8(6):579-85. PubMed ID: 22992152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal calprotectin: the proof is in the pudding.
    Cangemi JR
    J Clin Gastroenterol; 2012 Jul; 46(6):440-1. PubMed ID: 22688140
    [No Abstract]   [Full Text] [Related]  

  • 26. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective comparative study for new rapid bedside fecal calprotectin test with an established ELISA to assess intestinal inflammation.
    Shastri Y; Povse N; Stein J
    Clin Lab; 2009; 55(1-2):53-5. PubMed ID: 19350850
    [No Abstract]   [Full Text] [Related]  

  • 28. [Research advances in the role of fecal calprotectin in intestinal development and diseases among children].
    Li F; Sheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1064-9. PubMed ID: 25344194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rectal NO and fecal calprotectin in IBD.
    Lundberg JO
    Scand J Gastroenterol; 2009; 44(1):128. PubMed ID: 19101857
    [No Abstract]   [Full Text] [Related]  

  • 31. [FECAL NONINVASIVE TESTS (CALPROTECTIN, TRANSFERRIN, HEMOGLOBIN) IN COMPLEX DIAGNOSIS OF DISEASES OF INTESTINES].
    Livzan MA; Lyalukova EA; Nechaeva G; Osipenko MF; Dolgih TI
    Eksp Klin Gastroenterol; 2015; (3):34-8. PubMed ID: 26281175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update of faecal markers of inflammation in children with cystic fibrosis.
    Lee JM; Leach ST; Katz T; Day AS; Jaffe A; Ooi CY
    Mediators Inflamm; 2012; 2012():948367. PubMed ID: 22988347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary juvenile polyp as a cause of elevated faecal calprotectin in an adult.
    Hodgson-Parnell L; Spence O; Chapple K
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30065053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stool calprotectin monitoring after small intestine transplantation.
    Mercer DF; Vargas L; Sun Y; Moreno AM; Grant WJ; Botha JF; Langnas AN; Sudan DL
    Transplantation; 2011 May; 91(10):1166-71. PubMed ID: 21460762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Calprotectin and Eosinophil-derived Neurotoxin in Healthy Children Between 0 and 12 Years.
    Roca M; Rodriguez Varela A; Donat E; Cano F; Hervas D; Armisen A; Vaya MJ; Sjölander A; Ribes-Koninckx C
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):394-398. PubMed ID: 28169973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases.
    Tursi A; Elisei W; Giorgetti G; Picchio M; Brandimarte G
    Scand J Gastroenterol; 2013 Nov; 48(11):1359-60. PubMed ID: 23971760
    [No Abstract]   [Full Text] [Related]  

  • 37. No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide.
    Fernell E; Fagerberg UL; Hellström PM
    Acta Paediatr; 2007 Jul; 96(7):1076-9. PubMed ID: 17465982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis.
    Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J
    Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.
    Stoll ML; Punaro M; Patel AS
    J Rheumatol; 2011 Oct; 38(10):2274-5. PubMed ID: 21965700
    [No Abstract]   [Full Text] [Related]  

  • 40. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
    Krzesiek E; Iwańczak B
    Pol Merkur Lekarski; 2010 Oct; 29(172):241-6. PubMed ID: 21207640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.